Goldman Sachs Group Inc Neuro Pace Inc Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Neuro Pace Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 139,843 shares of NPCE stock, worth $966,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,843Holding current value
$966,315% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
61Shares Held
18.7MCall Options Held
28.9KPut Options Held
7.5K-
Kck Ltd. Tortola, D85.62MShares$38.8 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA4MShares$27.7 Million1.19% of portfolio
-
Morgan Stanley New York, NY2.48MShares$17.2 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$16.8 Million2.63% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT778KShares$5.38 Million0.66% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $172M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...